The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zocchi, M. R.
Right arrow Articles by Poggi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zocchi, M. R.
Right arrow Articles by Poggi, A.
The Journal of Immunology, 1998, 161: 2938-2943.
Copyright © 1998 by The American Association of Immunologists

HIV-1 Tat Inhibits Human Natural Killer Cell Function by Blocking L-Type Calcium Channels1

M. Raffaella Zocchi2,*,{dagger}, Anna Rubartelli{dagger}, Paola Morgavi{dagger} and Alessandro Poggi{ddagger}

* Laboratory of Tumor Immunology, Scientific Institute San Raffaele, Milan, Italy; {dagger} Laboratory of Clinical Pathology, National Institute for Cancer Research, Genoa, Italy; and {ddagger} Laboratory of Immunopathology, National Institute for Cancer Research and Advanced Biotechnology Center, Genoa, Italy

Herein we show that functional phenylalkylamine-sensitive L-type calcium channels are expressed by human NK cells and are involved in the killing of tumor targets. Blocking of these channels by phenylalkylamine drugs does not affect effector/target cell binding but inhibits the release of serine esterases responsible for cytotoxicity. Interestingly, treatment of NK cells with HIV-1 Tat, which is known to affect several calcium-mediated events in immune cells, impairs their cytotoxic activity. In addition, Tat inhibits the rise in intracellular free calcium concentration upon cross-linking of the adhesion molecule CD11a, engaged during effector/target cell interaction, and the activation molecule CD16. Exogenous Tat does not influence NK-target cell binding but prevents NK cell degranulation. We propose that the molecular structure(s) on NK cells mediating the inhibitory effects HIV-1 Tat belong to L-type calcium channels, based on three lines of evidence: 1) binding of phenylalkylamine derivatives to these channels is cross-inhibited by Tat; 2) L-type calcium channels from NK cell lysates bind to Tat linked to Sepharose columns; 3) the inhibitory effect of HIV-1 Tat on NK cell function is prevented by the agonist of L-type calcium channels, Bay K 8644. Altogether, these results suggest that exogenous Tat is deeply involved in the impairment of NK cell function during HIV-1 infection.




This article has been cited by other articles:


Home page
J. Virol.Home page
B. Majumder, N. J. Venkatachari, S. O'Leary, and V. Ayyavoo
Infection with Vpr-Positive Human Immunodeficiency Virus Type 1 Impairs NK Cell Function Indirectly through Cytokine Dysregulation of Infected Target Cells
J. Virol., July 15, 2008; 82(14): 7189 - 7200.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad
Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination
J. Leukoc. Biol., July 1, 2008; 84(1): 27 - 49.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Semino, J. Ceccarelli, L. V. Lotti, M. R. Torrisi, G. Angelini, and A. Rubartelli
The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion
J. Leukoc. Biol., January 1, 2007; 81(1): 92 - 99.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Gomes, M. Savignac, M. D. Cabral, P. Paulet, M. Moreau, C. Leclerc, R. Feil, F. Hofmann, J.-C. Guery, G. Dietrich, et al.
The cGMP/Protein Kinase G Pathway Contributes to Dihydropyridine-sensitive Calcium Response and Cytokine Production in TH2 Lymphocytes
J. Biol. Chem., May 5, 2006; 281(18): 12421 - 12427.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Poggi, C. Prevosto, A.-M. Massaro, S. Negrini, S. Urbani, I. Pierri, R. Saccardi, M. Gobbi, and M. R. Zocchi
Interaction between Human NK Cells and Bone Marrow Stromal Cells Induces NK Cell Triggering: Role of NKp30 and NKG2D Receptors
J. Immunol., November 15, 2005; 175(10): 6352 - 6360.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Poggi, S. Negrini, M. R. Zocchi, A.-M. Massaro, L. Garbarino, S. Lastraioli, L. Gargiulo, L. Luzzatto, and R. Notaro
Patients with paroxysmal nocturnal hemoglobinuria have a high frequency of peripheral-blood T cells expressing activating isoforms of inhibiting superfamily receptors
Blood, October 1, 2005; 106(7): 2399 - 2408.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Zocchi, P. Contini, M. Alfano, and A. Poggi
Pertussis Toxin (PTX) B Subunit and the Nontoxic PTX Mutant PT9K/129G Inhibit Tat-Induced TGF-{beta} Production by NK Cells and TGF-{beta}-Mediated NK Cell Apoptosis
J. Immunol., May 15, 2005; 174(10): 6054 - 6061.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Poggi, A.-M. Massaro, S. Negrini, P. Contini, and M. R. Zocchi
Tumor-Induced Apoptosis of Human IL-2-Activated NK Cells: Role of Natural Cytotoxicity Receptors
J. Immunol., March 1, 2005; 174(5): 2653 - 2660.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Savignac, B. Gomes, A. Gallard, S. Narbonnet, M. Moreau, C. Leclerc, P. Paulet, B. Mariame, P. Druet, A. Saoudi, et al.
Dihydropyridine Receptors Are Selective Markers of Th2 Cells and Can Be Targeted to Prevent Th2-Dependent Immunopathological Disorders
J. Immunol., May 1, 2004; 172(9): 5206 - 5212.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. M. Spaggiari, P. Contini, A. Dondero, R. Carosio, F. Puppo, F. Indiveri, M. R. Zocchi, and A. Poggi
Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction
Blood, December 1, 2002; 100(12): 4098 - 4107.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. M. Spaggiari, P. Contini, R. Carosio, M. Arvigo, M. Ghio, D. Oddone, A. Dondero, M. R. Zocchi, F. Puppo, F. Indiveri, et al.
Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily
Blood, March 1, 2002; 99(5): 1706 - 1714.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Poggi, R. Carosio, G. M. Spaggiari, C. Fortis, G. Tambussi, G. Dell'Antonio, E. Dal Cin, A. Rubartelli, and M. R. Zocchi
NK Cell Activation by Dendritic Cells Is Dependent on LFA-1-Mediated Induction of Calcium-Calmodulin Kinase II: Inhibition by HIV-1 Tat C-Terminal Domain
J. Immunol., January 1, 2002; 168(1): 95 - 101.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Gardella, C. Andrei, L. V. Lotti, A. Poggi, M. R. Torrisi, M. R. Zocchi, and A. Rubartelli
CD8+ T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1{beta} and cathepsin D
Blood, October 1, 2001; 98(7): 2152 - 2159.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Badou, Y. Bennasser, M. Moreau, C. Leclerc, M. Benkirane, and E. Bahraoui
Tat Protein of Human Immunodeficiency Virus Type 1 Induces Interleukin-10 in Human Peripheral Blood Monocytes: Implication of Protein Kinase C-Dependent Pathway
J. Virol., November 15, 2000; 74(22): 10551 - 10562.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. C. Gallo
Tat as one key to HIV-induced immune pathogenesis and Pat toxoid as an important component of a vaccine
PNAS, July 20, 1999; 96(15): 8324 - 8326.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Angelini, S. Gardella, M. Ardy, M. R. Ciriolo, G. Filomeni, G. Di Trapani, F. Clarke, R. Sitia, and A. Rubartelli
From the Cover: Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation
PNAS, February 5, 2002; 99(3): 1491 - 1496.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.